Follow-up of patients with early breast cancer: Is it time to rewrite the story?

Fabio Puglisi, Caterina Fontanella, Gianmauro Numico, Valentina Sini, Laura Evangelista, Francesco Monetti, Stefania Gori, Lucia Del Mastro

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The guidelines for follow-up in breast cancer survivors support only performance of periodic physical examination and annual mammography. However, medical oncologists and primary care physicians routinely recommend both blood tests and non-mammographic imaging tests in asymptomatic patients, leading to an increased anxiety related to false-positive results and higher medical expenses. Recently, advanced imaging technologies have improved sensitivity/specificity to detect metastatic lesions before symptoms arise. Considering the progress made in the treatment of metastatic disease and the rapid evolution of targeted therapy, that requires customization of the strategy according to molecular characteristics of the disease, patients could derive real benefit to early detection of disease recurrence. This hypothesis must be tested in a prospective clinical trial.

Original languageEnglish
Pages (from-to)130-141
Number of pages12
JournalCritical Reviews in Oncology/Hematology
Volume91
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Breast Neoplasms
Primary Care Physicians
Hematologic Tests
Mammography
Physical Examination
Survivors
Early Diagnosis
Anxiety
Clinical Trials
Guidelines
Technology
Recurrence
Sensitivity and Specificity
Therapeutics
Oncologists

Keywords

  • Early breast cancer
  • Follow-up
  • Surveillance
  • Survivorship care

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Follow-up of patients with early breast cancer : Is it time to rewrite the story? / Puglisi, Fabio; Fontanella, Caterina; Numico, Gianmauro; Sini, Valentina; Evangelista, Laura; Monetti, Francesco; Gori, Stefania; Del Mastro, Lucia.

In: Critical Reviews in Oncology/Hematology, Vol. 91, No. 2, 2014, p. 130-141.

Research output: Contribution to journalArticle

Puglisi, Fabio ; Fontanella, Caterina ; Numico, Gianmauro ; Sini, Valentina ; Evangelista, Laura ; Monetti, Francesco ; Gori, Stefania ; Del Mastro, Lucia. / Follow-up of patients with early breast cancer : Is it time to rewrite the story?. In: Critical Reviews in Oncology/Hematology. 2014 ; Vol. 91, No. 2. pp. 130-141.
@article{68f04a0b62874c9cb66a624ba10635a8,
title = "Follow-up of patients with early breast cancer: Is it time to rewrite the story?",
abstract = "The guidelines for follow-up in breast cancer survivors support only performance of periodic physical examination and annual mammography. However, medical oncologists and primary care physicians routinely recommend both blood tests and non-mammographic imaging tests in asymptomatic patients, leading to an increased anxiety related to false-positive results and higher medical expenses. Recently, advanced imaging technologies have improved sensitivity/specificity to detect metastatic lesions before symptoms arise. Considering the progress made in the treatment of metastatic disease and the rapid evolution of targeted therapy, that requires customization of the strategy according to molecular characteristics of the disease, patients could derive real benefit to early detection of disease recurrence. This hypothesis must be tested in a prospective clinical trial.",
keywords = "Early breast cancer, Follow-up, Surveillance, Survivorship care",
author = "Fabio Puglisi and Caterina Fontanella and Gianmauro Numico and Valentina Sini and Laura Evangelista and Francesco Monetti and Stefania Gori and {Del Mastro}, Lucia",
year = "2014",
doi = "10.1016/j.critrevonc.2014.03.001",
language = "English",
volume = "91",
pages = "130--141",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Follow-up of patients with early breast cancer

T2 - Is it time to rewrite the story?

AU - Puglisi, Fabio

AU - Fontanella, Caterina

AU - Numico, Gianmauro

AU - Sini, Valentina

AU - Evangelista, Laura

AU - Monetti, Francesco

AU - Gori, Stefania

AU - Del Mastro, Lucia

PY - 2014

Y1 - 2014

N2 - The guidelines for follow-up in breast cancer survivors support only performance of periodic physical examination and annual mammography. However, medical oncologists and primary care physicians routinely recommend both blood tests and non-mammographic imaging tests in asymptomatic patients, leading to an increased anxiety related to false-positive results and higher medical expenses. Recently, advanced imaging technologies have improved sensitivity/specificity to detect metastatic lesions before symptoms arise. Considering the progress made in the treatment of metastatic disease and the rapid evolution of targeted therapy, that requires customization of the strategy according to molecular characteristics of the disease, patients could derive real benefit to early detection of disease recurrence. This hypothesis must be tested in a prospective clinical trial.

AB - The guidelines for follow-up in breast cancer survivors support only performance of periodic physical examination and annual mammography. However, medical oncologists and primary care physicians routinely recommend both blood tests and non-mammographic imaging tests in asymptomatic patients, leading to an increased anxiety related to false-positive results and higher medical expenses. Recently, advanced imaging technologies have improved sensitivity/specificity to detect metastatic lesions before symptoms arise. Considering the progress made in the treatment of metastatic disease and the rapid evolution of targeted therapy, that requires customization of the strategy according to molecular characteristics of the disease, patients could derive real benefit to early detection of disease recurrence. This hypothesis must be tested in a prospective clinical trial.

KW - Early breast cancer

KW - Follow-up

KW - Surveillance

KW - Survivorship care

UR - http://www.scopus.com/inward/record.url?scp=84903478998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903478998&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2014.03.001

DO - 10.1016/j.critrevonc.2014.03.001

M3 - Article

C2 - 24726438

AN - SCOPUS:84903478998

VL - 91

SP - 130

EP - 141

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -